Gurbel, Paul A.
Tantry, Udaya S.
Article History
First Online: 6 October 2016
Competing interests
: P.A.G. has received consulting fees from AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi Sankyo/Lilly, Haemonetics, Janssen Pharmaceuticals, Merck, and New Haven Pharmaceuticals; grants from Coramed Technologies, Duke Clinical Research Institute, Haemonetics, Harvard Clinical Research Institute, MedImmune, Merck, National Institutes of Health, New Haven Pharmaceuticals, and Sinnowa. He also owns a patent for platelet function testing, and stock options in Merck. U.S.T. declares no competing interests.